Arthritis & Rheumatology

Prothrombotic Activation of Platelet Pannexin 1 Channels in Antiphospholipid Syndrome
Mazetto Fonseca BM, NaveenKumar SK, Yalavarthi S, Sugur K, Newman TG, Hoy CK, Sarosh C, Schaefer JK, Tambralli A, Madison JA, Zuo Y, Orsi F, Holinstat M and Knight JS
ATP is released from platelets through both degranulation and pannexin-1 (PANX1) channels. ATP then activates P2X receptors to amplify platelet activation via calcium-dependent signaling.
Serious Infections in Offspring Exposed to Tumour Necrosis Factor Inhibitors During Pregnancy: Comparison of Timing During Pregnancy and Placental Transfer Ability
Flatman LK, Bernatsky S, St-Pierre Y, Beauchamp ME, Malhamé I, Bérard A and Vinet É
We evaluated serious infection risk in offspring exposed to tumour necrosis factor inhibitors (TNFi) in utero, separated by TNFi timing and placental transfer ability.
Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis
Adami G, Pollastri F, Fassio A, Montanari F, Piccinelli A, Benini C, Pasetto E, Dartizio C, Gatti D, Rossini M and Viapiana O
Transition from long-term denosumab to PTH-analogs or romosozumab might expose patients to the risk of the so-called rebound phenomenon. Adding romosozumab to denosumab might represent an option in patients experiencing a fracture while on denosumab. The aim of this study was to investigate the effects of the combination of romosozumab to denosumab in post-menopausal osteoporosis.
Redlining, Structural Racism, and Psoriatic Arthritis Outcomes: Underrecognized Limitations and Clinical Implications
Chen SC and Lee YT
Authors' Reply
Xiang S
The impact of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: 10-year results from an inception cohort
Torgutalp M, Rios Rodriguez V, Proft F, Protopopov M, Rademacher J, Haibel H, Sieper J, Rudwaleit M and Poddubnyy D
This study aims to investigate the impact of non-steroidal anti-inflammatory drug (NSAID) intake on radiographic spinal progression in axial spondyloarthritis (axSpA), considering different NSAID types (COX-2 inhibitors [COX2i] and non-selective NSAIDs [ns-NSAIDs]) and disease subgroups (radiographic (r-axSpA) and non-radiographic (nr-axSpA).
Dosing Biologic Drugs for Patients with Obesity: One Size Does NOT Fit All
Balevic SJ, Gonzalez D and Meibohm B
Drugs induced Raynaud's phenomenon and underlying mechanism: a disproportionality analysis from the WHO pharmacovigilance database
Hlavaty A, Dari L, Cracowski JL, Roustit M and Khouri C
The aim of this study is to generate hypotheses about unknown drugs associated with the onset or worsening of Raynaud's Phenomenon (RP) and to explore their potential pathophysiological mechanisms through a mixed disproportionality/clustering analysis from the WHO pharmacovigilance database.
Letter to Editor: The limitations on Urate's Role in Knee Osteoarthritis Studies
Wang Q and Xing S
STOP-ing Rheumatoid Arthritis - Lessons Learned from the Latest Prevention Trial
Cope AP, Filer A and Bridges SL
Reinterpreting the Efficacy of IL-1 Inhibitors in VEXAS Syndrome: A Matter of Superiority or Sequencing?
Ding Z, Zhang T and Zhang S
Autoantigen peptide-8-arm PEG-Dyes (APP-Dyes) specifically recognize antigen-specific B cells and improve the diagnosis of rheumatoid arthritis
Liu S, Shi C, Cao L, Huang J, Xie Y, Wei C, Xiong Y, Shen B, Cai X, Li T, Zhu D, Yao R, Lin W, Jin X, Wang P, Fang X, Li Y, Zhu H, Ding Y, Guo Q, Chang T, Shi L, Qiu X, Zhou Z, Li Z and Hu F
Rheumatoid arthritis (RA) is a systemic chronic disabling autoimmune disease with high autoantibody production. However, approximately 1/3 of RA patients are autoantibodies-negative lacking biomarkers. Antigen-specific B cells are critical participants in RA pathogenesis by producing autoantibodies, driving inflammation and joint damage. Nevertheless, the limited detection methods have impeded in-depth studies on these cells. This study aimed to develop a novel probe to precisely recognize these cells and evaluate their diagnostic potential for RA.
Low-Grade Proteinuria Does Not Predict Favorable Outcomes in Lupus Nephritis: A Longitudinal Cohort Study
Shen Y, Peng J, Dai D, Dai M, Li T, Chen S, Ye S, Shen N and Ding H
To investigate the clinical characteristics, renal pathology treatment responses, and renal outcomes of lupus nephritis (LN) patients with different levels of baseline proteinuria.
Interleukin-33 Promotes Interstitial Lung Disease in Idiopathic Inflammatory Myopathy via ERK-Mediated Epithelial-Mesenchymal Transition: ERK as a potential therapeutic target
Yang J, Li W, Zhu J, Cui X, Chai H, Su Q, Guo J, Feng Y, Huang Z, Lv Y and Zhang S
Interstitial lung disease (ILD) is the most common and prognostically severe complication of idiopathic inflammatory myopathy (IIM), for which targeted treatments remain limited. Based on previous findings that neutrophil extracellular traps (NETs) are key mediators in IIM-ILD pathogenesis and given the established role of IL-33 in promoting NETosis, we hypothesized.
Unusual Cervical Pain in Ankylosing Spondylitis: Eagle Syndrome
Fares S, Madani A, Soyfoo M and Tant L
Reply to Redlining, Structural Racism, and Psoriatic Arthritis Outcomes
Dowell S, Holladay EE, Curtis JR and Kerr GS
MDSC-derived IFN-β promotes T follicular helper cell response and exacerbates lupus development
Rui K, Chen Z, Liu J, Huang W, Wang X, Xiao F, Zhou Y, Dai X, Tang Y, Zhao M, Peng N, Wang X, Zhu B, Wang S, Lu L and Tian J
Increasing evidence highlights a critical role of T follicular helper (Tfh) cells in autoimmune pathogenesis. This study aimed to identify inflammatory cytokines involved in driving Tfh cell responses in systemic lupus erythematosus (SLE).
Are Glucocorticoids Associated with Worse Survival among Rheumatoid Arthritis Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors?
Jannat-Khah D, Curtis JR, Xie F, Saxena A and Bass AR
Glucocorticoids are commonly used for rheumatoid arthritis (RA) treatment and to palliate some malignancies, but it is unclear whether glucocorticoids attenuate the benefits of immune checkpoint inhibitor (ICI) cancer therapy. We examined the association between glucocorticoid use and survival among ICI-treated RA patients with metastatic non-small cell lung cancer (mNSCLC).
Exposure to occupational inhalants and the risk of developing rheumatoid arthritis: A systematic review and meta-analysis
Liu Q, Song X, Mauro E, Jiang Y, Shchetynsky K, Klareskog P, Alfredsson L and Jiang X
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint pain, swelling, and stiffness. While smoking is a well-established risk factor for RA, the role of occupational inhalants in RA development is less well recognized. This study aimed to systematically review and synthesize existing evidence on the association between occupational inhalants and the risk of developing RA.
Testing the Possibility of Preventing Systemic Lupus Erythematosus
Costenbader KH, Touma Z and Mosca M
Special Issue: ACR Convergence 2025 October 24-29, 2025 Chicago, IL
For a searchable version of these abstracts, please visit www.acrabstracts.org.